References
- Bartek JJ, Sjavik K, Stahl F, et al. Surgery for chronic subdural hematoma in nonagenarians: a Scandinavian population-based multicenter study. Acta Neurol Scand 2017;136:516–20. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=28382656
- Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 2017;127:732–9.
- Stubbs DJ, Davies BM, Bashford T, et al. Identification of factors associated with morbidity and postoperative length of stay in surgically managed chronic subdural haematoma using electronic health records: a retrospective cohort study. BMJ Open 2020;10:e037385.
- Edlmann E, Giorgi-Coll S, Whitfield PC, et al. Pathophysiology of chronic subdural haematoma: Inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017;14:13.
- Foelholm R, Waltimo O. Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien) 1975;32:247–50. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med1&NEWS=N&AN=1225014
- Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N. Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 1992;32:207–9. http://www.ncbi.nlm.nih.gov/pubmed/1378564
- Rauhala M, Luoto TM, Huhtala H, et al. The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg 2020;132:1147–57.
- Alkhachroum AM, Fernandez-Baca Vaca G, Sundararajan S, et al. Post-subdural hematoma transient ischemic attacks: hypoperfusion mechanism supported by quantitative electroencephalography and transcranial doppler sonography. Stroke 2017;48:e87–e90.
- Slotty PJ, Kamp MA, Steiger SHJ, et al. Cerebral perfusion changes in chronic subdural hematoma. J Neurotrauma 2013;30:347–51.
- Yokoyama K, Matsuki M, Shimano H, et al. Diffusion tensor imaging in chronic subdural hematoma: correlation between clinical signs and fractional anisotropy in the pyramidal tract. AJNR Am J Neuroradiol 2008;29:1159–63.
- Adhiyaman V, Chattopadhyay I, Irshad F, et al. Increasing incidence of chronic subdural haematoma in the elderly. QJM 2017;110:375–8.
- Stubbs DJ, Vivian ME, Davies BM, et al. Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature. Acta Neurochir (Wien) 2021;163:2629–37.
- Asghar M, Adhiyaman V, Greenway MW, et al. Chronic subdural haematoma in the elderly-a North Wales experience. J R Soc Med 2002;95:290–2. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed7&NEWS=N&AN=34666506
- Mellergard P, Wisten O. Operations and re-operations for chronic subdural haematomas during a 25-year period in a well defined population. Acta Neurochir (Wien) 1996;138:708–13. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed6&NEWS=N&AN=26276563
- Magalhães MJ, da S de Araújo JP, Paulino A, et al. Epidemiology and estimated cost of surgery for chronic subdural hematoma conducted by the unified health system in Brazil (2008–2016). Arq Bras Neurocir 2019;38:79–85.
- Neifert SN, Chaman EK, Hardigan T, et al. Increases in subdural hematoma with an aging population—the future of american cerebrovascular disease. World Neurosurg 2020; 141:e166–74–e174.
- Hutchinson PJ, Edlmann E, Bulters D, et al. Trial of dexamethasone for chronic subdural hematoma. N Engl J Med 2020;383:2616–27.
- Haldrup M, Ketharanathan B, Debrabant B, et al. Embolization of the middle meningeal artery in patients with chronic subdural hematoma-a systematic review and meta-analysis. Acta Neurochir (Wien) 2020;162:777–84.
- The Society for British neurosurgeons (SBNS). National Neurosurgical Audit Program (NNAP). Last accessed October 16th 2021. Available from: https://www.sbns.org.uk/index.php/audit
- Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 2009;374:1067–73.
- Stubbs DJ, Davies BM, Menon DK. Chronic subdural haematoma: the role of perioperative medicine in a common form of reversible brain injury. Anaesthesia 2022; 77 (Suppl 1): 21–33.
- Royal Academy of Engineering. Engineering better care: a systems approach to health and care design and continuous improvement. London: Royal Academy of Engineering; 2017.
- Middleton M. Orthogeriatrics and hip fracture care in the UK: factors driving change to more integrated models of care. Geriatr 2018;3.55.
- The National Emergency Laparotomy Project Team. Fourth Patient Report of the National Emergency Laparotomy Audit (NELA). London; 2018. Available from: https://www.nela.org.uk/reports
- Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: A systematic review and meta-analysis. J Orthop Trauma 2014;28:e49–e55.
- NHS Providers. Right place, right time. Better transfers of care: a call to action; 2015. Available from: http://nhsproviders.org/media/1258/nhsp-right-place-lr.pdf
- Bapat S, Shapey J, Toma A, et al. Chronic subdural haematomas: a single-centre experience developing an integrated care pathway. Br J Neurosurg 2017;31:434–8.
- Tools and resources. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. Guidance: NICE. 2021. Available from: https://www.nice.org.uk/guidance/ng128/resources [last accessed 11 Mar 2021].
- The ‘Improving Care in Elderly Neurosurgery Initiative’ (ICENI). 2020. Available from: https://www.improving-care.in/neurosurgery[last accessed 4 Dec 2020].
- Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ 2009;181:165–8.
- Royal College of Physicians. The falls and fragility audit program: The National Hip Fracture Database. 2020. Available from: https://www.nhfd.co.uk/ [last accessed 30 Oct 2020].
- JN, CC, RW, et al. The impact of a national clinician-led audit initiative on care and mortality after hip fracture in England: an external evaluation using time trends in non-audit data. Med Care 2015;53:686–91.
- Griffin XL, Achten J, Parsons N, WHiTE orators, et al. Does performance-based remuneration improve outcomes in the treatment of hip fracture? Bone Joint J 2021;103-B:881–7.
- Pickard J, Richards H, Seeley H, et al. UK Shunt Registry Report 2017; 2017. Available from: https://brainhtc.org/wp-content/uploads/2017/10/UKSRDraftReport2017FINAL.pdf
- Holl DC, Chari A, Iorio-Morin C, et al. Study protocol on defining core outcomes and data elements in chronic subdural haematoma. Neurosurgery 2021;89:720–5.
- National Institute for Academic Anaesthesia Health Services Research Centre. The National Emergency Laparotomy Audit. 2020. Available from: https://www.nela.org.uk/ [last accessed 20 Nov 2020].
- Poulsen FR, Halle B, Pottegard A, et al. Subdural hematoma cases identified through a Danish patient register: diagnosis validity, clinical characteristics, and preadmission antithrombotic drug use. Pharmacoepidemiol Drug Saf 2016;25:1253–62. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=27384945
- Edlmann E, Whitfield PC, Kolias A, et al. Pathogenesis of chronic subdural hematoma: a cohort evidencing de novo and transformational origins. J Neurotrauma. 2021;38:2580–9.
- Christopher E, Poon MTC, Glancz LJ, Hutchinson PJ, Kolias AG, Brennan PM; British Neurosurgical Trainee Research Collaborative (BNTRC). Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma. Neurosurg Rev 2019;42:427–31.
- Whitehouse KJ, Jeyaretna DS, Enki DG, et al. Head injury in the elderly: what are the outcomes of neurosurgical care? World Neurosurg 2016;94:493–500.
- NHS Digital. Secondary Uses Services (SUS). 2021. Available from: https://digital.nhs.uk/services/secondary-uses-service-sus [last accessed 26 Aug 2021].
- Imam T, Konstant-Hambling R, Fluck R, et al. The hospital frailty risk score-outcomes in specialised services. Age Ageing 2021;50:511–8.
- NHS Specialised Clinical Frailty Network. Specialised Clinical Frailty Network. 2021. Available from: https://www.scfn.org.uk/ [last accessed 24 May 2021].
- Centre for perioperative care. Guideline for Perioperative Care for People Living with Frailty Undergoing Elective and Emergency Surgery. 2021. Available from: https://www.cpoc.org.uk/sites/cpoc/files/documents/2021-09/CPOC-BGS-Frailty-Guideline-2021.pdf [last accessed 8 Oct 2021].
- Griffiths R, Babu S, Dixon P, et al. Guideline for the management of hip fractures 2020: guideline by the Association of Anaesthetists. Anaesthesia 2021;76:225–37.
- Venturini S, Fountain DM, Glancz LJ, et al. Time to surgery following chronic subdural hematoma: post hoc analysis of a prospective cohort study. BMJ Surg Interv Health Technologies 2019;1:e000012.
- Scerrati A, Pangallo G, Dughiero M, et al. Influence of nutritional status on the clinical outcome of patients with chronic subdural hematoma: a prospective multicenter clinical study. Nutr Neurosci 2021;5:1–8.doi: 10.1080/1028415X.2021.1895480
- Murthy SB, Wu X, Diaz I, et al. Non-traumatic subdural hemorrhage and risk of arterial ischemic events. Stroke 2020; 51:1464–9.
- MTC P CR, AG K, et al. Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma 2021;38:1177–84.
- Keeling D, Campbell Tait R, Watson H. Peri-operative management of anticoagulation and antiplatelet therapy: a British Society for Haematology Guideline. 2021. Available from: https://b-s-h.org.uk/guidelines/guidelines/peri-operative-management-of-anticoagulation-and-antiplatelet-therapy/ [last accessed 9 Feb 2021].
- Wada M, Yamakami I, Higuchi Y, et al. Influence of antiplatelet therapy on postoperative recurrence of chronic subdural hematoma: a multicenter retrospective study in 719 patients. Clin Neurol Neurosurg 2014;120:49–54.
- Nagalla S, Sarode R. Role of platelet transfusion in the reversal of anti-platelet therapy. Transfus Med Rev 2019;33:92–7.
- Alfirevic A, Downing J, Daras K, et al. Has the introduction of direct oral anticoagulants (DOACs) in England increased emergency admissions for bleeding conditions? A longitudinal ecological study. BMJ Open 2020;10:e033357.
- Pollack CV, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015;373:511–20.
- Piran S, Khatib R, Schulman S, et al. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Adv 2019;3:158–67.
- National Institute for Health and Care Excellence. Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban [TA697]. 2021. Available from: https://www.nice.org.uk/guidance/ta697/chapter/1-Recommendations [last accessed 24 May 2021].
- Saja K. British Society for Haematology - Haemostasis and Thrombosis Task Force. Addendum to the guideline on the peri-operative management of anticoagulation and antiplatelet therapy. 2021. Available from: https://b-s-h.org.uk/media/19825/addendum-to-the-guideline-on-peri-operative-management-of-anticoagulation-and-antiplatelet-therapy.pdf [last accessed 26 Aug 2021].
- Ondexxya 200 mg powder for solution for infusion - Summary of Product Characteristics (SmPC) - (emc). Eur. Med. Compend. 2021. Available from: https://www.medicines.org.uk/emc/product/10933/smpc#gref [last accessed 24 May 2021].
- Scottish Medicines Consortium. Andexanet Alfa. 2021. Available from: https://www.scottishmedicines.org.uk/medicines-advice/andexanet-alfa-ondexxya-full-smc2273/ [last accessed 24 May 2021].
- Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 2014;259:449–57.
- Guilfoyle MR, Hutchinson PJA, Santarius T. Improved long-term survival with subdural drains following evacuation of chronic subdural haematoma. Acta Neurochir (Wien) 2017;159:903–5.
- Dakurah TK, Iddrissu M, Wepeba G, et al. Chronic subdural haematoma: review of 96 cases attending the Korle Bu Teaching Hospital, Accra. West Afr J Med 2005;24:283–6.
- Phang I, Sivakumaran R, Papadopoulos MC. No association between seniority of surgeon and postoperative recurrence of chronic subdural haematoma. annals 2015;97:584–8.
- Chelvarajah R, Lee JK, Chandrasekaran S, et al. A clinical audit of neurosurgical bed usage. Br J Neurosurg 2007;21:610–3.
- Chari A, Clemente Morgado T, Rigamonti D. Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 2014;28:2–7.
- Guha D, Coyne S, Macdonald RL. Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. JNS 2016;124:750–9.
- The British Society of Rehabilitation Medicine. Specialist neuro-rehabilitation services: providing for patients with complex rehabilitation needs. Last accessed 16th October 2021. Available from: https://www.bsrm.org.uk/downloads/specialised-neurorehabilitation-service-standards–7-30-4-2015-forweb.pdf
- Kwon CS, Al-Awar O, Richards O, et al. Predicting prognosis of patients with chronic subdural hematoma: a new scoring system. World Neurosurg 2018;109:e707–e714.
- Edlmann E, Holl DC, Lingsma HF, et al. Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach. Acta Neurochir (Wien) 2020;162:763–76.
- Moran CG, Lecky F, Bouamra O, et al. Changing the system - major trauma patients and their outcomes in the NHS (England) 2008-17. EClinicalMedicine 2018;2–3:13–21.
- van der Scheer, J.W., Woodward, M., Ansari, A., Draycott, T., Winter, C., Martin, G., Kuberska, K., Richards, N., Kern, R. and Dixon-Woods, M., 2021. How to specify healthcare process improvements collaboratively using rapid, remote consensus-building: a framework and a case study of its application. BMC medical research methodology, 21(1), pp.1–16.
- Moffatt CE, Hennessy MJ, Marshman LAG, et al. Long-term health outcomes in survivors after chronic subdural haematoma. J Clin Neurosci 2019;66:133–137. doi: 10.1016/j.jocn.2019.04.039.
- Dumont TM, Rughani AI, Goeckes T, et al. Chronic subdural hematoma: a sentinel health event. World Neurosurg 2013;80:889–92. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=52644318
- Bothwell LE, Greene JA, Podolsky SH, et al. Assessing the gold standard-lessons from the history of RCTs. N Engl J Med 2016;374:2175–81.
- Oyinlola JO, Campbell J, Kousoulis AA. Is real world evidence influencing practice? A systematic review of CPRD research in NICE guidances. BMC Health Serv. Res 2016;16:299.
- Williams I, Bryan S, McIver S. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach. J Health Serv Res Policy 2007;12:73–9.
- Lewis SC, Warlow CP, Bodenham AR, et al. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008;372:2132–42.